WHC is still in active development. Read this to understand our approach.
depiction of ZTVQQQVZCWLTDF-UHFFFAOYSA-N.svg
isomerdesign

Remifentanil

Verificar en isomerdesign

pubchem

Remifentanil

Verificar en pubchem

drugmap

Remifentanil

Verificar en drugmap

wiki

Remifentanil

Verificar en wiki

Data

InChI: InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3

Sinónimos: SB17331,Remifentanyl,methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate,Methyl(3-[4-methoxycarbonyl]-4-(N-phenyl-propanamido)piperidino)propanoate,GI 87084X,Ultiva-,Remifentanil [INN:BAN],methyl 1-(3-methoxy-3-oxopropyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate,1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester,REMIFENTANIL [WHO-DD],ramifentanyl,GTPL7292,P10582JYYK, GI 87084B, 4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester,D08473,REMIFENTANIL,UNII-P10582JYYK,methyl 1-(3-methoxy-3-oxopropyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate, Methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate,132875-61-7, 1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester, Remifentanil (INN),C08021,DEA No. 9739,REMIFENTANIL [MI], Ultiva,DB00899, 3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester,ZINC538283, GI 87084X, GI87084B,Q417902,SCHEMBL36652,REMIFENTANIL [INN],HSDB 8377,Remifentanil (INN), Ultiva (TN),Ultiva,1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester,L001266,4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-1-piperidinepropanoic acid methyl ester, Remifentanil [INN:BAN],Remifentanil,4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester,CHEBI:8802,DTXSID00157826,BIDD:GT0029,Ultiva (TN),IDS-NR-005,DB-042144,CHEMBL1005,REMIFENTANIL [VANDF]

Estimated data

Solubilidad: -2.565 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 86.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.